Genus Prime

Which are the latest news on Genus Prime?

Why is Genus Prime Infra Ltd falling/rising?

As of 04-Sep, Genus Prime Infra Ltd's stock price is at Rs. 49.23, up 4.99%, significantly outperforming the Sensex, which has declined. The stock has reached a new 52-week high and shows strong bullish trends despite a drop in investor participation.

As of 04-Sep, Genus Prime Infra Ltd's stock price is rising, currently at Rs. 49.23, reflecting an increase of Rs. 2.34 or 4.99%. This rise is supported by several factors. The stock has outperformed the benchmark Sensex, which has seen a decline of 0.97% over the past week, while Genus Prime has surged by 23.79% in the same period. Over the last month, the stock has gained 51.66%, contrasting with a 2.44% drop in the Sensex.<BR><BR>Additionally, the stock has reached a new 52-week high today, indicating strong upward momentum. It has been on a consecutive gain streak for the last five days, contributing to its impressive return of 23.79% during this timeframe. The stock opened with a gap up of 4.99% today and has maintained this price level throughout the trading session.<BR><BR>Moreover, Genus Prime is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically signals a bullish trend. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 50.13% against the 5-day average. Despite this, the stock remains liquid enough for trading, indicating that the current rise is likely driven by positive market sentiment and strong performance metrics rather than high trading volume.

Who are in the management team of Genus Prime?

The management team of Genus Prime includes Amit Agarwal (Whole Time Director & CEO), Simpal Agarwal (Director), and independent directors Dharam Chand Agarwal, Kamal Kant Agarwal, and Udit Agarwal.

The management team of Genus Prime includes the following individuals:<BR><BR>1. Dharam Chand Agarwal - Independent Director<BR>2. Kamal Kant Agarwal - Independent Director<BR>3. Amit Agarwal - Whole Time Director & CEO<BR>4. Simpal Agarwal - Director<BR>5. Udit Agarwal - Independent Director<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Genus Prime do?

Genus Prime Infra Ltd, a micro-cap company in the commodity chemicals sector, focuses on real estate development and reported net sales of 1 Cr and a net profit of 2 Cr for June 2026. It operates as a subsidiary of Genus Paper Products Limited with a market cap of INR 318 Cr.

Overview:<BR>Genus Prime Infra Ltd operates in the commodity chemicals industry as a micro-cap company, focusing primarily on real estate development.<BR><BR>History:<BR>Incorporated in 2000, Genus Prime Infra Ltd was formerly known as Gulshan Chemfill Ltd. The company currently operates as a subsidiary of Genus Paper Products Limited and has reported its latest quarterly results for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 1 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 2 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 318 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 52.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.18 <BR>Return on Equity: 2.12% <BR>Price to Book: 1.41 <BR><BR>Contact Details:<BR>Address: Near Moradabad Dharam Kanta, Kanth Road Harthala Moradabad Muzaffarnagar Uttar Pradesh : 244001 <BR>Tel: 91-591-2511171 <BR>Email: cs.genusprime@gamil.com <BR>Website: http://www.genusprime.com

Who are the peers of the Genus Prime?

Genus Prime's peers include Mangalam Organic, Lords Chloro, Alufluoride, National Perox., Andhra Petrochem, Hind.Organ.Chem., IVP, ARCL Organics, and ZR2 Bioenergy. Genus Prime has the highest 1-year return at 72.28%, while ZR2 Bioenergy has the lowest at -70.89%.

Peers: The peers of Genus Prime are Mangalam Organic, Lords Chloro, Alufluoride, National Perox., Andhra Petrochem, Hind.Organ.Chem., IVP, ARCL Organics, and ZR2 Bioenergy.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride and ARCL Organics, while Average management risk is found at Mangalam Organic, Lords Chloro, Andhra Petrochem, and IVP. Below Average management risk is noted at Genus Prime, National Perox., Hind.Organ.Chem., and ZR2 Bioenergy. Growth is rated as Good for Lords Chloro, Alufluoride, Genus Prime, and ARCL Organics, while Below Average growth is seen at Mangalam Organic, National Perox., Andhra Petrochem, Hind.Organ.Chem., and IVP. Capital Structure is rated as Excellent for National Perox., Good for Lords Chloro, Andhra Petrochem, Alufluoride, and ARCL Organics, and Below Average for Genus Prime, Mangalam Organic, Hind.Organ.Chem., IVP, and ZR2 Bioenergy.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Genus Prime at 72.28%, while the peer with the lowest is ZR2 Bioenergy at -70.89%. Genus Prime's 1-year return is significantly higher than all its peers. Additionally, the peers with negative six-month returns include ZR2 Bioenergy and DCM Shriram Fine.

How big is Genus Prime?

As of 31st August, Genus Prime Infra Ltd has a market capitalization of 318.00 Cr, with recent net sales of 4.89 Cr and a net profit of 6.06 Cr. Shareholder's funds are 46.17 Cr and total assets are valued at 66.83 Cr as of March 2025.

As of 31st August, Genus Prime Infra Ltd has a market capitalization of 318.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Genus Prime reported Net Sales of 4.89 Cr and a Net Profit of 6.06 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 46.17 Cr and Total Assets valued at 66.83 Cr.

Should I buy, sell or hold Genus Prime Infra Ltd?

When is the next results date for Genus Prime Infra Ltd?

The next results date for Genus Prime Infra Ltd is 10 August 2026.

The next results date for Genus Prime Infra Ltd is scheduled for 10 August 2026.

Are Genus Prime Infra Ltd latest results good or bad?

Genus Prime Infra Ltd's latest results show a significant profit increase of 2,540% to ₹3.96 crores, largely driven by non-operating income, while net sales declined by 5.69%. Despite improved operating margins, the reliance on other income and low return on equity indicate underlying challenges, suggesting caution for investors.

The latest results for Genus Prime Infra Ltd present a mixed picture. On one hand, the company reported a consolidated net profit of ₹3.96 crores for Q4 FY26, which is a remarkable increase of 2,540% compared to the previous quarter. This surge in profit is impressive; however, it is largely attributed to a significant reliance on other income, which accounted for 76.32% of profit before tax. This raises concerns about the sustainability and quality of the earnings.<BR><BR>On the other hand, net sales for the same quarter were ₹1.16 crores, reflecting a decline of 5.69% from the previous quarter. While this represents a staggering year-on-year growth of 5,700% from a very low base, the sequential drop indicates inconsistency in revenue generation. The operating margin, excluding other income, was exceptionally high at 131.9%, up from 67.48% in the previous quarter, suggesting improved cost management, but again, the sustainability of such margins is questionable given the company's current scale.<BR><BR>Moreover, the return on equity (ROE) remains very low at 0.19%, indicating weak capital efficiency. Overall, while the profit figures may seem positive at first glance, the heavy reliance on non-operating income and the decline in sales suggest that the underlying business is facing significant challenges. Therefore, the results can be viewed as concerning rather than outright good. Investors should approach with caution, considering the potential risks associated with the company's financial health and operational consistency.

Is Genus Prime overvalued or undervalued?

As of November 17, 2025, Genus Prime is considered very expensive and overvalued, with a PE ratio of 75.33 and an EV to EBITDA of 43.64, significantly higher than its peers, and has experienced an 18.60% year-to-date decline compared to an 8.72% rise in the Sensex.

As of 17 November 2025, the valuation grade for Genus Prime has moved from risky to very expensive. This indicates a significant shift in perception regarding the company's valuation, suggesting that it is currently overvalued. The company’s PE ratio stands at an exceptionally high 75.33, while its EV to EBITDA ratio is 43.64, both of which are considerably above industry norms. Additionally, the PEG ratio is a mere 0.02, indicating that the stock is priced excessively relative to its growth potential.<BR><BR>In comparison to its peers, Genus Prime's valuation metrics are starkly higher than those of Godrej Industries, which has a PE ratio of 37.63 and an EV to EBITDA of 40.96, making it appear relatively more attractive. Other peers, such as Gujarat Fluoroch, also show lower valuations with a PE of 57.85 and an EV to EBITDA of 31.25. Given these ratios and the overall market context, Genus Prime is deemed overvalued. Despite a strong historical performance over the long term, recent returns indicate a decline, with a year-to-date drop of 18.60% compared to an 8.72% rise in the Sensex, reinforcing the concerns about its current valuation.

How has been the historical performance of Genus Prime?

Genus Prime has consistently reported low net sales and negative profitability, with stable sales figures around 0.22 Cr but significant losses, particularly in Mar'24. The company faces ongoing financial challenges, reflected in negative profit margins and declining reserves.

Answer:<BR>The historical performance of Genus Prime shows a consistent trend of low net sales and negative profitability over the years.<BR><BR>Breakdown:<BR>Genus Prime's net sales have remained relatively stable, with figures of 0.22 Cr in Mar'25, Mar'23, and Mar'22, while slightly decreasing from 0.23 Cr in Mar'24 and Mar'20. The total operating income mirrored this trend, remaining at 0.22 Cr for Mar'25, Mar'23, and Mar'22. However, the company's total expenditure saw a significant spike in Mar'24 to 2.23 Cr, leading to an operating profit of -2.00 Cr, which improved to -0.04 Cr in Mar'25. The profit before tax followed a similar pattern, with a loss of -2.00 Cr in Mar'24 and a reduced loss of -0.04 Cr in Mar'25. The profit after tax also reflected these losses, with -2.00 Cr in Mar'24 and -0.04 Cr in Mar'25. The company's total liabilities decreased from 69.57 Cr in Mar'24 to 66.83 Cr in Mar'25, while total assets also declined from 69.57 Cr to 66.83 Cr in the same period. Cash flow from operating activities was non-existent in recent years, indicating challenges in generating cash from core operations. Overall, Genus Prime has faced ongoing financial difficulties, reflected in its negative profit margins and declining reserves.

Who are the top shareholders of the Genus Prime?

The top shareholder of Genus Prime is promoter Rajendra Agarwal, holding 29.26%. Other notable shareholders include Arham Vyapaar Private Limited at 3.57% and individual investors with a collective 18.66%.

The top shareholders of Genus Prime include Rajendra Agarwal, who is the promoter with the highest holding at 29.26%. The company does not have any pledged promoter holdings, and there are no mutual funds or foreign institutional investors holding shares. The highest public shareholder is Arham Vyapaar Private Limited, which holds 3.57%. Additionally, individual investors collectively hold 18.66% of the shares.

What is the technical trend for Genus Prime?

As of May 26, 2025, Genus Prime's technical trend is mildly bullish, supported by daily moving averages and Bollinger Bands, despite some caution from weekly and monthly MACD and KST indicators.

As of 26 May 2025, the technical trend for Genus Prime has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and KST are both mildly bearish, suggesting some caution. However, the Bollinger Bands on both weekly and monthly time frames are bullish, supporting the overall mildly bullish trend. The Dow Theory shows a mildly bullish signal on the weekly chart but no trend on the monthly. Despite recent underperformance in the weekly return compared to the Sensex, the longer-term returns are significantly strong, particularly over 3, 5, and 10 years. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and Bollinger Bands.

Has Genus Prime declared dividend?

No Dividend History Available